Acrivon Therapeutics将公布其Acr-368正在进行的2B阶段研究及计划的确认性3期试验的临床进展,同时更新Acr-2316的初步临床数据及其他AP3管线进展

美股速递
Dec 17, 2025

Acrivon Therapeutics将公布其Acr-368正在进行的2B阶段研究及计划的确认性3期试验的临床进展,同时更新Acr-2316的初步临床数据及其他AP3管线进展。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10